NOV 11, 2019 11:00 AM PST

Optimizing Antimicrobial Stewardship by Combining Multiplex PCR and Biomarker Results in Patients with Sepsis

Sponsored by: bioMérieux Inc
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Co-Director of the Antimicrobial Stewardship Program and a Clinical Infectious Diseases Pharmacist at Duke Regional Hospital in Durham, North Carolina
    Biography
      Dr. John Boreyko is the Co-Director of the Antimicrobial Stewardship Program and a Clinical Infectious Diseases Pharmacist at Duke Regional Hospital in Durham, North Carolina. Dr. Boreyko received his Doctorate of Pharmacy at the University of North Carolina at Chapel Hill and is a Board Certified Infectious Diseases Pharmacist. Dr. Boreyko has been utilizing biomarkers and diagnostics for almost ten years and spearheaded the implantation and education at his hospital.

    Abstract:

    DATE: November 11, 2019
    TIME: 11:00am PST

    This webinar will explore how using VIDAS® B•R•A•H•M•S PCT™ (procalcitonin) and BIOFIRE® FILMARRAY® Blood Culture Identification Panel results can optimize antimicrobial stewardship in patients with sepsis.

     

    Learning Objectives:

    • Discuss how to reduce antibiotic exposure with highly predictive low procalcitonin levels and positive highly multiplexed blood culture identification panel results                       
    • Explain the high incidence of unnecessary antibiotics in viral infections  

     

    Webinars will be available for unlimited on-demand viewing after live event.

     

    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

     


    Show Resources
    You May Also Like
    SEP 05, 2019 4:00 PM CEST
    C.E. CREDITS
    SEP 05, 2019 4:00 PM CEST
    DATE: September 5, 2019TIME: 7:00am PT, 10:00am ET, 4:00pm CEST PCR (Polymerase Chain Reaction) has gone through a massive evolution since its development in 1983. Besides it...
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    OCT 31, 2019 9:00 AM PDT
    C.E. CREDITS
    OCT 31, 2019 9:00 AM PDT
    DATE: October 31, 2019TIME: 9:00am PDT, 12:00pm EDT INTRODUCTION: A major limitation for the development of 3D engineered tissues is the absence of viable and perfusable...
    SEP 27, 2019 9:00 AM PDT
    C.E. CREDITS
    SEP 27, 2019 9:00 AM PDT
    DATE: September 27, 2019TIME: 9:00am PT, 12:00pm ET Thienopyrazole derivatives have recently emerged as effective antitumoral agents with kinase inhibitory activity. In this s...
    DEC 05, 2019 5:00 AM PST
    C.E. CREDITS
    DEC 05, 2019 5:00 AM PST
    DATE: December 5, 2019TIME: 5:00am PST, 8:00am EST The diagnosis of an active infection by the hepatitis B virus (HBV) relies on testing for the HBV surface antigen (HBsAg). Ov...
    AUG 27, 2019 9:00 AM PDT
    C.E. CREDITS
    AUG 27, 2019 9:00 AM PDT
    DATE: August 27, 2019 TIME: 9:00am PDT, 12:00pm EDT Immunotherapies targeting PD-1 or PD-L1 have proven remarkably effective for treating cancer in some patients, with considerabl...
    Loading Comments...
    Show Resources